Health Populi

JUNE 24, 2021

The economic and healthcare system impacts of this were explored in the Post-Covid Healthcare Landscape , delivered by Fitch Solutions’ Jamie Davies and Beau Noafshar, leaders in the Pharmaceuticals, Healthcare, and Medical Devices groups. spends on NASA.

BioTech 270

BioTech Pharmaceuticals Public Health Telehealth 270

Healthcare IT Today

APRIL 21, 2023

Series B funding proceeds will enable Scene to further accelerate its ability to serve Medicaid and Medicare managed care plans, pharmaceutical companies, and clinical research organizations. Scene reaching a milestone of impacting more than 200,000 lives with over 40M engagements through its 360° model of care.

Life Science 57

Life Science Medicare Public Health Nursing 57

Health Populi

OCTOBER 15, 2019

And this is not only for providers and plans, but for pharma and life science companies, as well. Do not assume that older people, and especially “younger older” Medicare members between 65 and 74 don’t increasingly feel this way.

Medical Billing 235

Medical Billing Life Science Medicare Pharmaceuticals 235

Health Populi

NOVEMBER 19, 2019

In the past decade, I’ve been spending a lot of time considering SDoH through a variety of lenses across the health/care ecosystem, including care providers like hospitals, health insurance companies, pharma and life science, retail health care front doors, and non-profits and foundations.

Medicare 149

Medicare Life Science Leadership Pharmaceuticals 149

Healthcare IT Today

NOVEMBER 28, 2023

I think that we saw a lot of movement during COVID, we saw a lot of commercial insurers actually move toward covering more telehealth services, and we saw Medicare increase coverage for telehealth services, but we need more.

Mental health 69

Mental health Life Science Healthcare IT Telehealth 69

Henry Kotula

JULY 1, 2019

The trend has implications for employers, payers, providers and even pharmaceutical and life science companies. For payers, it becomes important to benchmark the prices paid commercially against a common reference point such as Medicare. WHAT ELSE YOU SHOULD KNOW.

Life Science 32

Life Science Pharmaceuticals Mental health Telemedicine 32

Lloyd Price

OCTOBER 16, 2018

They are focused on creating strategic partnerships to develop a cross-company strategy for health care and life sciences innovation. Verily Verily, formerly Google Life Sciences, was founded in 2015. It seems like a lot of well-placed investments for Alphabet, however, that’s only one side of the story.

Life Science 60

Life Science Primary Care Interoperability EHR 60

Health Populi

OCTOBER 8, 2019

Pricing failure, the second big waste factor, is predominantly challenged by pharmaceutical/prescription drug pricing based on this research. The Centers for Medicare and Medicaid Services (CMS) forecasts that prescription drug spending will be the fastest-growing cause of rising health spending by 2027. patients).

Pharmaceuticals 260

Pharmaceuticals Medicare Life Science Health Policy 260

Healthcare IT News - Telehealth

AUGUST 9, 2021

IT vendor Salesforce is rolling out new healthcare tools designed to help healthcare and life sciences organizations meet their patients, members and customers where they are to deliver the right care, at the right time, from anywhere. Since RPM is not considered a telehealth service, it did not face those restrictions.

Telehealth 147

Telehealth Life Science Remote care EHR 147

HIStalk Interviews

JANUARY 28, 2019

The other important corporate standard is around decision-making for medical devices and pharmaceuticals. We’re rolling out a clinical trial product to address the needs of the pharmaceutical companies and medical device companies that we serve, but also the technology companies that want to get a piece of this robust market.

Life Science 60

Life Science Pharmaceuticals EHR Medicare 60

Health Populi

APRIL 30, 2021

What will be normal within that normal is that millions of people will still feel anxious, stressed, and worried about post-Corona life in peoples’ heads, hearts, and wallets. As such, the debate on prescription drug pricing in the U.S.

Pharmaceuticals 156

Pharmaceuticals Mental health Medicare Life Science 156

Healthcare IT Today

JANUARY 9, 2023

Jesse Cugliotta, Global Industry GTM Lead, Healthcare & Life Sciences at Snowflake. This is not sustainable when so many of the active pharmaceutical ingredients and medical device components we rely on come from a small handful of countries. This could be a breakthrough for the pharmaceutical industry.

Health IT 93

Health IT Pharmaceuticals Drug Development Life Science 93

Health Populi

MAY 14, 2018

Smart Pharmaceuticals Index (NQSSPH) from May 11, 2018, the date when POTUS and Secretary Azar made their announcement. Incentives for lowering list prices for medicines, such as FDA requiring that drug companies include list prices in ads and bringing more transparency to Medicare drug pricing and generic competition, and.

Pharmaceuticals 120

Pharmaceuticals Medicare Life Science BioTech 120

Health Populi

MARCH 6, 2019

is prescription drug prices — that they’re too high, that the Federal government should negotiate to lower costs for Medicare enrollees, and that out-of-pocket costs for drugs should be limited. That would be profits made by pharmaceutical companies, cited by 80% of respondents. consumers were asked.

Pharmaceuticals 140

Pharmaceuticals Life Science Medicare BioTech 140

Health Populi

JUNE 18, 2020

The authors, Dr. Naci and Dr. Kesselheim, are affiliated with the London School of Economics and Brigham and Women’s Hospital in Boston, note that 1% of medicines dispensed under Medicare Part D and Medicaid accounted for nearly $1 in $3 of drug spending in each program in 2015. bn to $32.8 bn to $9.9 bn for Medicaid.

BioTech 191

BioTech Medicare Life Science Telehealth 191

Health Populi

JUNE 3, 2021

adults note that expanding Medicare to including hearing aids, dental and vision coverage would be their top or an important priority, shown in the second line in the bar chart on public priorities. States to negotiate with drug companies to get lower prices on Rx meds in their state, and. On the cost-front, 90% of U.S.

Medicare 170

Medicare Life Science BioTech Pharmaceuticals 170

Health Populi

FEBRUARY 4, 2020

voters in 2020 quite like supporting Medicare’s ability to negotiate drug prices with pharmaceutical companies, shown by the October 2019 Kaiser Family Foundation Health Tracking Poll. In this poll, the top strategy is via Medicare negotiation, above re-importation, reference pricing, and other tactics gauged in the survey.

Pharmaceuticals 193

Pharmaceuticals Medicare Leadership Life Science 193

Health Populi

MAY 19, 2019

They don’t tend to shop around for health care or be super-engaged in their care, probably because they tend to be older and more likely to be covered by Medicare. They may be threatened by a call for “Medicare for All” given their affection for the program.

Life Science 149

Life Science BioTech Medicare Medical Billing 149